🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⏰ Deadline Approaching ⏰ DUE May 31 Submit your manuscripts to the upcoming special issue in #ACSMedChemLett highlighting the exciting collaborations in #DrugDiscovery happening across the academic and industrial divide 🤝 More information ➡ go.acs.org/czU

The May issue of #ACSMedChemLett is out today! Dr. Amanda Dombrowski highlights three must read articles this month In this Issue. go.acs.org/czZ

Congratulations to #ACSMedChemLett Editor-in-Chief Kelly Chibale (Kelly Chibale) on his election to the National Academy of Sciences!

📢Prof Kelly Chibale joins #WCP2026 Thrilled to announce Prof Kelly Chibale, UCT's pioneering drug discovery expert and H3D Centre Director, will keynote at the 20th World Congress of Pharmacology! wcp2026.org #ASCEPT #IUPHAR

A new Perspective in #JMedChem shares lived experiences and strategies to overcome Afrocentric barriers in advancing medicinal chemistry in Africa. go.acs.org/cAY

Joint Special Issue from #JMedChem and #ACSMedChemLett Many Faces of Medicinal Chemistry, celebrating the exciting research happening around the world from both academic and industrial institutions. Read here ➡ go.acs.org/cBa!

Gastrin-releasing peptide receptor is a promising target for #cancer #radiotheranostics. In #ACSMedChemLett, Tsuchihashi et al. report a novel GRPR-targeted radioligand with favourable pharmacokinetics & a high-level accumulation in tumours. pubs.acs.org/doi/10.1021/ac… ACS Publications Bio & Med Chem Content

Meet the Winners of 2025 the Philip S. Portoghese Joint Lectureship Awards. Find out more: go.acs.org/cCs

📢 New Special Issue from #ACSInfectiousDiseases #JMedChem and #ACSMedChemLett 🍄 Fungal Pathogens: Life Cycle, Infection, Host Immunity and Drug Discovery Read the issue ➡ pubs.acs.org/page/si/fungal…

📣 New in #AngewChemIntEd: Woodland and Coertzen et al. show that the anticancer kinase inhibitor AZD0156 is a potent inhibitor of Plasmodium PI4Kβ and is an attractive candidate for medicinal chemistry optimisation against malaria 👨‍🔬 UCT IDM UCT onlinelibrary.wiley.com/doi/10.1002/an…

Discovery of INCB126503, a selective FGFR2/3 inhibitor with gatekeeper mutant coverage and clean PK/safety, published in ACS Med Chem Lett. #oncology #medchem #FGFR go.acs.org/cDK

Introducing the potential binding interface between a TRAIL-mimicking peptide and DR5 via alanine scan. Tripathi et al. used experimental + in silico methods to learn how this 16-residue peptide binds to the death receptor DR5. ACS Publications Bio & Med Chem Content #ACSMedChemLett pubs.acs.org/doi/10.1021/ac…

Now out in #JMedChem! 💊 We report SARs for sapanisertib, identifying analogues with improved safety profiles and dual inhibitory activities against high-value Plasmodium targets PI4Kβ and PKG; a selected compound achieved an in vivo proof-of-concept 🐭 pubs.acs.org/doi/10.1021/ac…

Happening Now: Impactful Conversation with Kedest, Kelly Chibale, Janet Midega( Janet Midega), Fredros Okumu and Yaw Bediako under the theme: Connecting the Dots—How can we Strengthen Collaborations to Drive Scientific & Economic Progress. #ADIS25 #InvestInAfrica

Benzosuberene and Tetracyclic Analogues as Inhibitors of Tubulin Polymerization Expand Colchicine Site SAR as Potential Cancer Therapeutic Agents. #ACSMedChemLett Kevin Pinney go.acs.org/cFp